Table 2 |.
Inhibition kinetics model fitting parameters
| Inhibitor | Kinetic Model | KT urate (µM) 1 | KI (µM) 1 | Vmax (pmol min−1 mg−1)1 | Sy.x 2 |
|---|---|---|---|---|---|
| BBR | Competitive | 26.08 [11.29 –48.59] |
0.00213 [0.001 – 0.0042] |
1591 [1355 – 1846] |
306.7 |
| Non-Competitive | 32.4 [20.7 – 47.9] |
0.033 [0.025 – 0.045] |
1700 [1530 – 1881] |
231.0 | |
| LESU | Competitive | 162.8 [126.4 – 210.1] |
0.348 [0.275 – 0.439] |
3625 [3335 – 3955] |
196.3 |
| Non-Competitive | 175.1 [148.8 – 206.5] |
1.63 [1.46 – 1.82] |
3725 [3522 – 3947] |
137.2 | |
| TD-3 | Competitive | 82.19 [59.19 – 113.0] |
0.079 [0.057 – 0.111] |
2259 [2071 – 2472] |
208.0 |
| Non-Competitive | 115.3 [99.21 – 130.4] |
0.44 [0.38 – 0.50] |
2515 [2393 – 2644] |
122.1 |
Fit value with 95% confidence interval [lower value – upper value].
Model fit quality as reported by the standard deviation of the residuals, where and is the number of data points (18) and is the number of fitting parameters (3). When comparing two models, a lower value denotes a better fit. For all inhibitors tested, non-competitive models yield superior fits.